* Equity distribution agreement with Maxim Group Llc where
co may offer, sell from time to time, through maxim up to 3.7
million shares

Source text for Eikon:
Further company coverage:

The post BRIEF-Viking Therapeutics’ equity distribution agreement with Maxim Group appeared first on NASDAQ.